Sarcopenia is a multifactorial syndrome that occurs with age and results in loss of skeletal muscle mass and function (Rosenberg et al, Clin. Geriatr. Med. 2011). It begins approximately from 30 years of age. From then on, between 3 and 8% of muscle mass is lost with up to 40% of muscle mass loss after attaining 80 years of age. Although physical changes begin to manifest at advanced ages, recent studies have shown that changes at the cellular and molecular levels precede the symptomatology of sarcopenia (Sayed et al, Exp. Gerontol. 2016) (Del Campo et al, Aging. 2018). Importantly, another highly rampant disease, namely obesity, is accompanied with loss of muscle mass and presents with muscle dysfunction, but occurs independent of aging. It is thought that increased inflammatory markers in obesity inhibit muscle protein synthesis, causing skeletal muscle dysfunction (Studenski et al, J. Gerontol. A. Biol. Sci. Med. Sci. 2014). Series of studies have shown that in the obese state, monocyte-derived macrophages are recruited into tissues and produce cytokines such as TNF, leading to systemic inflammation, ectopic lipid accumulation, and insulin resistance (Kim et al, Mol. Ther. Nucleic. Acids. 2016) (McLaughlin et al, J. Clin. Invest. 2017).
Tissue macrophages are known to play important roles in tissue homeostasis, repair, immunity, and pathophysiology. They exhibit different transcriptomes in response to signals within the tissue microenvironment, enabling tissue-specific functions. In the current study, we aim to investigate the direct impact of obesity on skeletal muscle-resident macrophages, and if there’s a causal link to skeletal muscle function. Therefore, we first assessed muscle functions of young-lean (20 weeks-old), old-lean (18 months-old), and young-obese (20 weeks-old) male mice. The db/db mouse, which is a well characterized model of the hyperphagia that results in obesity and classic attendant metabolic disease, was used as the obese model in our study. All assessments of muscle function-maximal tetanic force, maximal twitch force, and force frequency-fall with age, but were even lower in the young obese mice. These results indicate that obesity accelerated the aging features of skeletal muscle function. Furthermore, we analyzed a publicly available single-cell RNA-sequencing (scRNA-seq) data from the limb muscles of aging mice (Tabula Muris Senis), and found that there were clear immune system alterations and a decrease in muscle satellite cells from 3 to 18 months of age. In aged mice, the B and T cell populations almost disappeared (a typical sign of immune senescence), while a specific subpopulation of macrophages emerged. In the future study, we will investigate whether the aging-specific subpopulation of macrophages appear in young-obese skeletal muscle. Moreover, both in vitro culture system and bioinformatics approaches can be applied to identify the effect of aging-specific subpopulation of macrophages on skeletal muscle cells.
In summary, we successfully obtained the sign of accelerated sarcopenic phenotypes in both aging and obesity conditions. By combining the further analyses on aging-specific subpopulation of macrophages using scRNA-seq data, it is promising to demonstrate that tissue macrophages exposed to chronic stress, such as obesity, can influence the pathogenesis of sarcopenia.